ESMO 2023丨Andrea Nccchi: Novel Intravesical Drug Delivery System Helps Bladder Cancer Patients Preserve Bladder, Reduce Risk of Recurrence
At the 2023 European Society of Medical Oncology (ESMO 2023), Dr. Andrea Nccchi reported a phase 2b clinical study at the mini oral presentation, using a new intravesical local chemotherapy delivery system. TAR200 is expected to become a treatment method for patients with high-risk non-muscle invasive bladder (HR MIBC) to reduce disease recurrence. In addition, ESMO 2023 also reported TAR201 and EV-302 study. Dr. Andrea Nccchi shared his views on these latest studies in an interview with " Oncology Frontier ".
ESMO in 5 Minutes | Professor Man Li: Advances in Early Breast Cancer Treatment
Editor's Note: The primary goal for early-stage breast cancer patients is cure, and numerous studies have explored treatment strategies based on this objective. In this edition of the ESMO conference,…
AASLD Exclusive Interview | Dr.Mark Yarchoan: Progress in the Treatment of Intermediate and Advanced HCC, Highlighting the Value of Systemic Therapy
Editor's Note: At the recently concluded international annual flagship event in the field of hepatology – the American Association for the Study of Liver Diseases Annual Meeting (AASLD 2023), Professor…
ESMO 2023丨Professor Feng Jin: CLEVER Study – Repurposing Old Drugs for Targeting Dormant Tumor Cells to Prevent High-Risk Breast Cancer Recurrence
Editor's note: Previous studies have indicated a close association between disseminated tumor cells (DTC) in the bone marrow and breast cancer recurrence. At the 2023 ESMO conference, data from the…
Interview with Chao Zhuo at ECCMID 2023
The 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) took place in Copenhagen, Denmark, from April 15th to 18th, 2023. As one of the most significant conferences in the field of clinical microbiology and infectious diseases, it marked a significant gathering after a three-year hiatus due to the pandemic. Chinese experts, including Dr. Chao Zhuo from The First Affiliated Hospital of Guangzhou Medical University, were present to share their insights.
Dr. Junqi Niu’s Team: Revealing Changes in Human Hepatic Stellate Cells, Discovering Potential Diagnostic and Therapeutic Targets for Liver Fibrosis
Liver cirrhosis is a prevalent condition worldwide, closely associated with the progression of chronic liver diseases and a critical precursor to liver cell carcinoma. Due to its insidious onset and…
The Cure Puzzle: Key Factors in Curing Metastatic Sarcoma Explored with Professor Silvia Stacchiotti
Engaging in a critical discussion on the topic of "When can we cure patients with metastatic sarcoma?" Professor Silvia Stacchiotti provided invaluable insights during an exclusive interview with Oncology Frontier…
ESMO 2023: Advancements in Oncology, Honoring Excellence, and the Global Impact
ESMO 2023: Advancements in Oncology, Honoring Excellence, and the Global Impact
The European Society for Medical Oncology (ESMO) 2023 Congress held in Madrid was a momentous event that brought together oncology professionals and researchers from across the globe. This comprehensive article delves into the key highlights of this remarkable event, encapsulating the essence of the President's speech, WHO officials' insights, the Scientific Chair's vision, the issuance of prestigious ESMO Awards, and the thought-provoking speeches delivered by each ESMO Award-winning expert. It's an exploration of the evolving landscape of oncology, the global fight against cancer, and the exceptional contributions of individuals in the field.